15 August 2020>: Clinical Research
Extracellular Vesicle-Transported Long Non-Coding RNA (LncRNA) X Inactive-Specific Transcript (XIST) in Serum is a Potential Novel Biomarker for Colorectal Cancer Diagnosis
Jinfeng Yu 1ABE , Weiwei Dong 2FG , Jianxiao Liang 3CD*DOI: 10.12659/MSM.924448
Med Sci Monit 2020; 26:e924448
Supplementary Table 1 Demographic characteristics of the CRC patients.
No. | Type | Stage | M | D | TS | Gender | Age | OS (months) | Status |
---|---|---|---|---|---|---|---|---|---|
1 | CRC | I | Y | High | Male | 66 | 18 | Dead | |
2 | CRC | II | N | Medium | Female | 51 | 24 | Dead | |
3 | CRC | III | Y | Low | >3 cm | Male | 63 | 36 | Dead |
4 | CRC | IV | Y | Low | Male | 38 | 60 | Live | |
5 | CRC | II | N | High | Male | 60 | 60 | Live | |
6 | CRC | IV | Y | Low | Female | 53 | 30 | Dead | |
7 | CRC | IV | N | Low | Female | 68 | 42 | Dead | |
8 | CRC | II | Y | Low | Male | 52 | 39 | Dead | |
9 | CRC | IV | N | Low | Male | 56 | 18 | Dead | |
10 | CRC | IV | Y | High | Female | 62 | 12 | Dead | |
11 | CRC | IV | Y | Low | >3 cm | Female | 66 | 18 | Dead |
12 | CRC | IV | Y | Low | Male | 71 | 15 | Dead | |
13 | CRC | IV | Y | High | >3 cm | Male | 61 | 36 | Dead |
14 | CRC | IV | N | Low | >3 cm | Male | 71 | 42 | Live |
15 | CRC | IV | Y | Low | Female | 67 | 30 | Dead | |
16 | CRC | III | Y | Low | Female | 66 | 39 | Dead | |
17 | CRC | IV | N | Medium | Male | 66 | 33 | Dead | |
18 | CRC | IV | Y | Medium | Male | 71 | 36 | Dead | |
19 | CRC | IV | Y | Low | >3 cm | Male | 58 | 45 | Live |
20 | CRC | III | Y | Low | Female | 64 | 30 | Dead | |
21 | CRC | IV | Y | Medium | >3 cm | Female | 58 | 15 | Dead |
22 | CRC | IV | Y | Medium | Female | 63 | 18 | Dead | |
23 | CRC | IV | N | Low | >3 cm | Female | 72 | 33 | Dead |
24 | CRC | I | Y | Low | >3 cm | Female | 65 | 36 | Dead |
25 | CRC | IV | N | Low | Male | 60 | 60 | Live | |
26 | CRC | IV | Y | Medium | >3 cm | Male | 60 | 24 | Dead |
27 | CRC | IV | N | Medium | Male | 61 | 24 | Dead | |
28 | CRC | III | Y | Medium | >3 cm | Female | 66 | 33 | Dead |
29 | CRC | III | N | Medium | >3 cm | Male | 71 | 39 | Dead |
30 | CRC | II | Y | Medium | Female | 58 | 24 | Dead | |
31 | CRC | III | Y | Low | >3 cm | Male | 66 | 60 | Live |
32 | CRC | III | N | Low | Female | 66 | 27 | Dead | |
33 | CRC | IV | Y | Low | >3 cm | Female | 65 | 39 | Dead |
34 | CRC | IV | Y | Low | >3 cm | Female | 64 | 36 | Dead |
35 | CRC | III | N | Medium | Male | 73 | 39 | Dead | |
36 | CRC | III | Y | Medium | >3 cm | Female | 73 | 27 | Dead |
37 | CRC | III | Y | Medium | Female | 66 | 45 | Dead | |
38 | CRC | III | Y | Low | >3 cm | Male | 68 | 54 | Dead |
39 | CRC | III | N | Medium | >3 cm | Female | 67 | 30 | Dead |
40 | CRC | III | Y | Medium | Male | 63 | 60 | Live | |
41 | CRC | III | Y | Medium | Female | 61 | 36 | Dead | |
42 | CRC | III | Y | Low | >3 cm | Male | 67 | 18 | Dead |
43 | CRC | III | N | Medium | >3 cm | Female | 68 | 15 | Dead |
44 | CRC | II | Y | Medium | Female | 47 | 27 | Dead | |
45 | CRC | III | Y | Medium | Male | 70 | 21 | Dead | |
46 | CRC | II | Y | Medium | >3 cm | Female | 67 | 36 | Dead |
47 | CRC | III | Y | Medium | >3 cm | Male | 73 | 21 | Dead |
48 | CRC | III | Y | Low | Male | 40 | 39 | Dead | |
49 | CRC | III | Y | Medium | Female | 55 | 54 | Dead | |
50 | CRC | III | N | Medium | >3 cm | Female | 53 | 51 | Live |
51 | CRC | II | N | Low | >3 cm | Male | 45 | 30 | Dead |
52 | CRC | II | N | Medium | >3 cm | Male | 65 | 33 | Dead |
53 | CRC | II | N | Medium | >3 cm | Male | 39 | 18 | Dead |
54 | CRC | II | N | High | >3 cm | Male | 47 | 27 | Dead |
55 | CRC | II | Y | Medium | >3 cm | Female | 72 | 60 | Live |
56 | CRC | II | N | High | >3 cm | Male | 60 | 27 | Live |
57 | CRC | III | N | High | Male | 49 | 36 | Dead | |
58 | CRC | II | N | High | Male | 54 | 33 | Dead | |
59 | CRC | II | N | High | Male | 41 | 60 | Live | |
60 | CRC | II | N | High | >3 cm | Male | 70 | 51 | Dead |
61 | CRC | II | Y | High | >3 cm | Female | 45 | 48 | Dead |
62 | CRC | II | N | Low | Male | 44 | 45 | Dead | |
63 | CRC | II | N | Low | Male | 56 | 45 | Dead | |
64 | CRC | II | N | Low | Male | 68 | 33 | Dead | |
65 | CRC | II | Y | Low | >3 cm | Female | 62 | 39 | Dead |
66 | CRC | IV | N | High | Female | 47 | 27 | Dead | |
67 | CRC | IV | N | High | Female | 43 | 60 | Live | |
68 | CRC | II | N | High | >3 cm | Male | 54 | 60 | Live |
69 | CRC | III | N | Medium | >3 cm | Male | 62 | 60 | Live |
70 | CRC | II | N | Medium | Male | 65 | 33 | Dead | |
71 | CRC | II | Y | High | >3 cm | Male | 43 | 45 | Dead |
72 | CRC | II | Y | High | Male | 50 | 48 | Dead | |
73 | CRC | I | N | High | >3 cm | Male | 65 | 51 | Live |
74 | CRC | I | N | Low | Male | 67 | 54 | Dead | |
75 | CRC | I | Y | High | Male | 45 | 57 | Dead | |
76 | CRC | IV | N | High | >3 cm | Female | 60 | 51 | Dead |
77 | CRC | IV | N | High | >3 cm | Male | 51 | 60 | Live |
78 | CRC | I | N | Low | >3 cm | Male | 53 | 48 | Dead |
79 | CRC | I | N | High | Male | 58 | 60 | Live | |
80 | CRC | I | Y | High | >3 cm | Male | 50 | 39 | Dead |
81 | CRC | III | N | High | >3 cm | Female | 68 | 27 | Live |
82 | CRC | I | Y | Low | >3 cm | Female | 53 | 36 | Dead |
83 | CRC | I | N | High | Male | 46 | 30 | Live | |
84 | CRC | III | N | Low | Male | 68 | 42 | Dead | |
85 | CRC | I | N | Low | Male | 41 | 30 | Dead | |
86 | CRC | III | N | High | Male | 45 | 57 | Dead | |
87 | CRC | III | N | Medium | >3 cm | Female | 64 | 42 | Dead |
88 | CRC | IV | N | Medium | Male | 73 | 42 | Live | |
89 | CRC | I | N | High | >3 cm | Male | 43 | 39 | Dead |
90 | CRC | IV | Y | High | Female | 58 | 45 | Dead | |
91 | CRC | I | N | Low | >3 cm | Female | 62 | 42 | Dead |
92 | CRC | III | N | High | >3 cm | Male | 47 | 33 | Live |
93 | CRC | I | Y | High | >3 cm | Male | 65 | 36 | Dead |
94 | CRC | I | N | High | >3 cm | Female | 68 | 30 | Dead |
M – stands for metastasis; D – stands for differentiation; TS – stands for tumor size; CRC – colorectal cancer. |